Key statistics
Valuation, profitability, and growth metrics
- Market cap
- 44.28B USD
- Enterprise value
- 52.22B USD
- Trailing P/E
- 20.55
- Forward P/E
- 16.16
- Price / sales
- 3.97
- Price / book
- 2.02
- EV / EBITDA
- 18.34
- Beta
- 0.24
- Dividend yield
- +1.97%
- Profit margin
- +14.55%
- Return on equity
- +10.09%
- Debt / equity
- 50.20
- Earnings growth
- -4.50%
- Revenue growth
- +2.20%
- Free cash flow
- 1.8B USD
- Operating cash flow
- 2.65B USD
- Shares outstanding
- 4.4B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Updated Sep 2, 2026, 4:06 AM